PBA
Paradigm Biocapital Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121M | Buy |
2,976,099
+365,902
| +14% | +$14.8M | 5.15% | 5 |
|
|
2025
Q1 | $134M | Buy |
2,610,197
+78,301
| +3% | +$4.02M | 6.14% | 6 |
|
|
2024
Q4 | $140M | Buy |
2,531,896
+91,451
| +4% | +$5.06M | 4.88% | 6 |
|
|
2024
Q3 | $80.3M | Buy |
2,440,445
+5,029
| +0.2% | +$165K | 2.72% | 9 |
|
|
2024
Q2 | $66.2M | Sell |
2,435,416
-427,990
| -15% | -$11.6M | 2.53% | 14 |
|
|
2024
Q1 | $104M | Buy |
2,863,406
+1,838,406
| +179% | +$66.8M | 3.66% | 11 |
|
|
2023
Q4 | $20.8M | Buy |
+1,025,000
| New | +$20.8M | 0.97% | 22 |
|